ResearcherHeidelberg UniversityActive in the last 2 years
Chao Fang
Matched on OpenAlex author ID A5160244710. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 37
2025: 3 papers · 2026: 2 papers
Papers 5
- Arp2/3 complex and β1 integrin drive an invasive front through extracellular matrix adaptation in pancreatic cancer. Co-author DOI 10.1002/ijc.70376↗
- Dual mTORC1/2 and Scd1 inhibition uncovers a therapeutic vulnerability in pancreatic cancer. Co-author DOI 10.1038/s41388-026-04026-x↗
- ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.35246↗
- Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. Co-author DOI 10.1016/j.xcrm.2024.101927↗
- ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. Co-author DOI 10.1038/s41388-025-03530-w↗
Closest collaborators
The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christoph W. Michalski · 5 shared papers, 2025–2026 · strength 1.03
- Paper Arp2/3 complex and β1 integrin drive an invasive front through extracellular matrix adaptation in pancreatic cancer. DOI 10.1002/ijc.70376↗
- Paper ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma. DOI 10.1002/ijc.35246↗
- Paper Dual mTORC1/2 and Scd1 inhibition uncovers a therapeutic vulnerability in pancreatic cancer. DOI 10.1038/s41388-026-04026-x↗
- Ingrid Herr · 5 shared papers, 2025–2026 · strength 1.03
- Paper Arp2/3 complex and β1 integrin drive an invasive front through extracellular matrix adaptation in pancreatic cancer. DOI 10.1002/ijc.70376↗
- Paper ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma. DOI 10.1002/ijc.35246↗
- Paper Dual mTORC1/2 and Scd1 inhibition uncovers a therapeutic vulnerability in pancreatic cancer. DOI 10.1038/s41388-026-04026-x↗
- Christoph Kahlert · 3 shared papers, 2025–2026 · strength 0.59
- Paper Arp2/3 complex and β1 integrin drive an invasive front through extracellular matrix adaptation in pancreatic cancer. DOI 10.1002/ijc.70376↗
- Paper Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. DOI 10.1016/j.xcrm.2024.101927↗
- Paper ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. DOI 10.1038/s41388-025-03530-w↗
- Yifeng Sun · 3 shared papers, 2025 · strength 0.57
- Paper ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma. DOI 10.1002/ijc.35246↗
- Paper Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. DOI 10.1016/j.xcrm.2024.101927↗
- Paper ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. DOI 10.1038/s41388-025-03530-w↗
- Helmut Frieß · 2 shared papers, 2025 · strength 0.41
- Martin Loos · 2 shared papers, 2025–2026 · strength 0.39
- Bo Kong · 2 shared papers, 2025–2026 · strength 0.38
- Helmut Friess · 2 shared papers, 2025–2026 · strength 0.38
- Zipeng Lu · 2 shared papers, 2025 · strength 0.34
- Susanne Roth · 2 shared papers, 2025 · strength 0.34
- Hongzhen Li · 2 shared papers, 2025 · strength 0.34
- Zhiheng Zhang · 2 shared papers, 2025 · strength 0.34
- Shuang Nie · 2 shared papers, 2025 · strength 0.34
- Jorg H. Kleeff · 2 shared papers, 2025 · strength 0.34
- Xiufen Yang · 1 shared paper, 2026 · strength 0.24
- Bo Kong · 1 shared paper, 2026 · strength 0.24
- Hend Abdelrasoul · 1 shared paper, 2026 · strength 0.24
- Benno Traub · 1 shared paper, 2025 · strength 0.23
- Bindhu K. Madhavan · 1 shared paper, 2025 · strength 0.23
- Bo Kong · 1 shared paper, 2025 · strength 0.23
- Thomas P. Hank · 1 shared paper, 2026 · strength 0.22
- Franco Fortunato · 1 shared paper, 2026 · strength 0.22
- Max Heckler · 1 shared paper, 2026 · strength 0.22
- İhsan Ekin Demir · 1 shared paper, 2026 · strength 0.22
- Xiaoping Zou · 1 shared paper, 2025 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.